Risk Comparison · Cached SEC Snapshots
AAPL vs RXRX — Structural Risk Comparison
AAPL
Apple Inc.
AA
MODERATE / CAUTION
Score: 75%
VS
RXRX
RECURSION PHARMACEUTICALS, INC.
C
MODERATE / CAUTION
Score: 0%
STRUCTURAL RISK ANALYSIS · DETERMINISTIC
RXRX SHOWS HIGHER STRUCTURAL RISK
RXRX has 902.2 fewer months of cash runway (96.8 mo vs 999.0 mo).
METRIC
AAPL
RXRX
SPREAD
Doomsday Clock
999.0 mo▲
96.8 mo▼
902.2 mo
Dilution Risk
-2.3 / 100▲
30.6 / 100▼
32.8 pts
Altman Z-Score
1.13▲
-1.34▼
2.47
Operating Cash Flow
$53.92B▲
-$81.1M▼
—
Net Income
$42.10B▲
-$117.5M▼
—
Current Ratio
0.97x▼
5.47x▲
—
Retained Earnings
-$2.18B▲
-$2.19B▼
—
Educational analysis only. Not financial advice. Comparison uses cached SEC EDGAR data and may contain inaccuracies. AI systems are fallible. Always verify against primary filings on
SEC EDGAR
and consult a licensed advisor before making investment decisions.